| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
101 |
84 |
$6K |
| M0223 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
12 |
12 |
$3K |
| 99305 |
|
64 |
64 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29 |
27 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
62 |
44 |
$2K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
52 |
51 |
$2K |
| 99306 |
Prolong nursin fac eval 15m |
25 |
24 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
37 |
36 |
$986.04 |
| 99307 |
|
75 |
57 |
$680.53 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
26 |
24 |
$479.64 |
| 99424 |
|
355 |
344 |
$101.56 |
| 36410 |
|
21 |
21 |
$58.96 |
| 99304 |
|
13 |
13 |
$31.69 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
126 |
77 |
$9.13 |
| 99426 |
|
46 |
46 |
$0.00 |